Contribution of HIV infection to mortality among cancer patients in Uganda. - Wikidata - wikimedia - TriplyDB

Contribution of HIV infection to mortality among cancer patients in Uganda.

Contribution of HIV infection to mortality among cancer patients in Uganda.

http://www.wikidata.org/entity/Q35056551

about

A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008 HIV Infection and Survival Among Women With Cervical Cancer.South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment.Deaths ascribed to non-communicable diseases among rural Kenyan adults are proportionately increasing: evidence from a health and demographic surveillance system, 2003-2010 Building capacity for sustainable research programmes for cancer in Africa.The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin's lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study.Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States.Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.[HIV infection in patients with breast cancer in Guinea (West Africa)].African Breast Cancer-Disparities in Outcomes (ABC-DO): protocol of a multicountry mobile health prospective study of breast cancer survival in sub-Saharan Africa.Learning lessons from cancer centers in low- and middle-income countries.Strengthening care and research for women's cancers in Sub-Saharan Africa.Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer.HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities.Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic.Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute.Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11.

P2860

Q28647861-CE8DDB1E-6C22-4EE7-AD77-EDC72A8C93B8 Q33816855-D3A1A27C-7F58-44EB-8D1C-05D601B74DBC Q33859760-8B26F88B-2E10-47F6-B995-EAF4AA0C3014 Q34576654-F22BA46C-6A38-404E-825F-D5185A8CB4D9 Q35492988-9FE8C483-6CA4-4581-8B11-5C5EC47F6965 Q35552875-2B104454-C694-460B-A165-4DC01FB7C252 Q35847460-C637FA19-4C16-47CF-84BD-32A3DBD28E3E Q35865134-AA98FF25-C826-49ED-B06E-F9EDC0E925EA Q35921020-D2F2F7A1-A963-4B28-B847-58F557ECCC02 Q35942794-254DA11C-4567-4F55-9824-FB7A2CB8A75C Q36167713-2044A5F9-9535-4365-9519-84214E39B80D Q37236618-8CD7E57A-71C3-4404-B907-CF958E6BF7D3 Q37441731-80771C2C-6902-4492-B76F-691F17B8EC63 Q38368741-A68E1392-1D67-4E15-94CA-9C7FE63B49D7 Q38403451-6F3CAA63-9AEE-4532-ABA5-15FBBA922582 Q38944679-31D72B3A-58B6-47FF-8025-3BFE59B46A7F Q43048471-ECEA722D-BD77-4EA6-A6B3-207E0E7C2ABD Q46142571-6125E065-AC1C-4D14-910F-DC0F01B05327 Q46339308-C2075B72-B718-4365-8D44-6C77A742DA99 Q48123569-B5BDCABF-EE90-417C-A89C-03A7F6C718B3 Q50426099-27CB58A4-4117-46EA-9F1D-BB4FC29283D6

P2860

Contribution of HIV infection to mortality among cancer patients in Uganda.

http://www.wikidata.org/entity/Q35056551

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Contribution of HIV infection to mortality among cancer patients in Uganda.

@ast

Contribution of HIV infection to mortality among cancer patients in Uganda.

@en

type

label

Contribution of HIV infection to mortality among cancer patients in Uganda.

@ast

Contribution of HIV infection to mortality among cancer patients in Uganda.

@en

prefLabel

Contribution of HIV infection to mortality among cancer patients in Uganda.

@ast

Contribution of HIV infection to mortality among cancer patients in Uganda.

@en

P1433

Q35056551-497DE06A-EA76-4B97-B8A2-6FB3DCD4CCB9

P1476

Q35056551-6FF3D44D-9C0A-4ECB-BA28-A0AAB7EC9BEF

P2093

Q35056551-04C56BD8-0520-46A2-91EE-510BBC0010AE

Q35056551-4160F334-7607-4C1C-A090-97D1E4005187

Q35056551-63A8C81A-AADE-470C-A64D-B45477FC49D3

Q35056551-644A619F-22E6-48ED-9DB7-7E61EA4ACFB2

Q35056551-87EC6810-3890-4C77-BCD0-D7BAE1DABDC0

Q35056551-B9590793-BFBE-4A7C-81FD-D2A8202CB203

Q35056551-B9C949CF-3FE0-4211-BD72-C7AFF5CEF891

Q35056551-BC300B64-F161-41AD-AE6A-A490080877F6

Q35056551-D1E437D5-DDF5-48AB-8761-13D6F23B4EB2

P2860

Q35056551-06CEE9F3-199E-4746-B108-08A423E38F39

Q35056551-091FCD54-52E8-4556-AEBA-AFDF26CEA13B

Q35056551-0998EE86-7845-46FC-B60C-82391B05751E

Q35056551-0AF0B0B8-5F43-486A-858D-F80A0253775F

Q35056551-1F25C1CD-980E-4B4D-929A-A4BB21C043F1

Q35056551-237B61E6-D526-4C64-96D0-BD93250F5957

Q35056551-2FAA7103-5CE6-492E-A6CF-947FE7101547

Q35056551-304527E6-AAA6-4A83-B5E2-596AAD1799D1

Q35056551-31C209C2-CF03-430B-A5D3-D69FB6145AD0

Q35056551-320BB432-BF2D-467A-834F-026D265029F0

P304

Q35056551-7C0E549C-6F9B-49B8-850B-1EF0B7ABC7E5

P31

Q35056551-0F6F215D-8C1E-4B97-BBD5-197E60252633

P356

Q35056551-88CB12F8-E064-424F-B08E-D50AFCABD985

P407

Q35056551-D6FCAFB2-C566-4EA1-9346-B4E4D96A7B70

P433

Q35056551-5B4DF503-A289-4FA2-9E3B-63552BC10CF7

P478

Q35056551-08037D89-24A2-4215-BFCF-353CC4DA97E7

P50

Q35056551-1063C175-8174-408B-ABA0-C75D9EC9F2F4

P577

Q35056551-4C22FB9F-740E-4F29-98C7-CCD4CFBCE90C

P5875

Q35056551-FF694635-EBB9-4F31-8747-7532DE479BEE

P698

Q35056551-780D03B8-6E02-4B83-A716-4A2CBD929FEF

P921

Q35056551-60D3A6E9-CB58-4636-951F-4D57394A9DC5

P932

Q35056551-A4A965B6-DEBF-492F-A43A-8B4B6F7355A2

P356

01.AIDS.0000433236.55937.CB

P1433

P1476

Contribution of HIV infection to mortality among cancer patients in Uganda.

@en

P2093

Anna E Coghill

http://www.w3.org/2001/XMLSchema#string

Barbra A Richardson

http://www.w3.org/2001/XMLSchema#string

Corey Casper

http://www.w3.org/2001/XMLSchema#string

Fred Okuku

http://www.w3.org/2001/XMLSchema#string

Henry Wabinga

http://www.w3.org/2001/XMLSchema#string

Innocent Mutyaba

http://www.w3.org/2001/XMLSchema#string

Jackson Orem

http://www.w3.org/2001/XMLSchema#string

Margaret M Madeleine

http://www.w3.org/2001/XMLSchema#string

Warren Phipps

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Immune activation and inflammation in HIV-1 infection: causes and consequences

Inflammation and cancer

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection

Immunity, Inflammation, and Cancer

Inflammation and cancer: back to Virchow?

Cancer immunoediting: from immunosurveillance to tumor escape

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

P304

2933-2942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.AIDS.0000433236.55937.CB

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Polly A Newcomb

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255694662

http://www.w3.org/2001/XMLSchema#string

P698

23921614

http://www.w3.org/2001/XMLSchema#string

P921

P932

4319357

http://www.w3.org/2001/XMLSchema#string